1H. G. Schleich,W. Wiest,R. Schmidt,I. Hofmann,H. P. Altenburg,F. Melchert. Ovarian carcinoma: Increase in clinical validity by simultaneous determination of SRA and CA 125[J] 1987,Journal of Cancer Research and Clinical Oncology(6):603～607
2H. G. Schleich,W. Wiest. Increasing human serum ribonuclease activity is a concomitant phenomenon of ovarian carcinoma[J] 1980,Journal of Cancer Research and Clinical Oncology(3):307～314
5Bast RC Jr, Klug TL st, John E, et al. A radioimmumoassoy using a monoelonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883
6Li XG, Chen DX, Schwarts PE, et al. A study of the monoclonal antibody OC125 to diagnose malignant ovarian tumors. Gynecol Oncol 1989; 32: 227
7Halila H, Stenman Ulffaran, Seppala M, et al. Ovarian cancer antigen CA125 Levels in pelvic in flammatory disease and pregnancy. Cancer 1986; 57:1327
